Primary open-angle glaucoma cases to grow to 10 million by 2033

Japan has a significantly greater risk of normal tension glaucoma.

Primary open-angle glaucoma (POAG) cases are forecasted to increase to 10 million by 2033 with an annual growth rate of 1%, according to a GlobalData report.

The report said the increase is due to increased disease awareness and improved diagnostic testing across the seven major markets (7MM) including the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan.

Japan has a significantly greater risk of normal tension glaucoma (NTG) with epidemiologists anticipating that 91% of all POAG cases in the country will be NTG.

“More research is needed to understand why Japanese populations are at an increased risk for NTG. Understanding the risk factors that increase susceptibility could help inform prevention strategies and disease outcomes,” said Anna Moody, senior epidemiologist at GlobalData.

GlobalData epidemiologists also found that the prevalence of glaucoma increases as a person ages. In the 7MM, it is expected to be lowest from 40 to 49 years (0.1%), and highest in 80 to 84 years (2.5%).

“As the population of elderly people increases across the 7MM, more regular eye testing should be encouraged in individuals over 40 years to ensure prompt diagnosis of glaucoma,” Moody said.

Follow the link for more news on

GlobalData

Also Read

Global REM sleep behaviour disorder market to reach $438.6m by 2028

SG to launch national strategy for allied health professionals

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

I want to download the media kit

Top News

Global REM sleep behaviour disorder market to reach $438.6m by 2028

It is driven the increasing integration of AI and ML in RBD detection.

Healthcare

47 minutes ago

SG to launch national strategy for allied health professionals

It will also implement a mandatory continuing professional education by 2026.

Healthcare

19 hours ago

Bladder cancer cases to hit 340,000 by 2033

Older adults aged 60 and above make up about 87% of diagnosed cases.Bladder cancer cases in eight major markets, including Japan and China, are projected to grow at an annual rate of 2.24%, rising from 280,0000 cases in 2023 to 340,000 in 2033, according to GlobalData. The US will have the highest number of diagnosed cases at approximately 100,000, whilst France will report the lowest at 20,000 for 2023.Antara Bhattacharya, an associate project manager in GlobalData’s Epidemiology team, noted that men are more affected, comprising about 78% of cases, compared to 22% for women. Older adults aged 60 and above make up nearly 87% of diagnosed cases, with younger adults aged 18 to 59 accounting for about 13%.Roughly 45% of bladder cancer cases were diagnosed in early stages, with severe cases making up only 6%. Furthermore, about 79% of cases were detected at early tumour stages, compared to 4% in more advanced stages. Bhattacharya attributed the high diagnosis rates to the increased use of cystoscopy, an invasive diagnostic procedure. However, even with early-stage diagnosis, relapse and recurrence remain common, affecting approximately 74% of cases.Bladder cancer, the ninth most common type of cancer, poses challenges due to the cost and complexity of timely detection. Bhattacharya emphasised the need for comprehensive research and improved medical strategies to enhance early detection and treatment. Ongoing epidemiological studies focusing on stages of bladder cancer with a high likelihood of recurrence can contribute to better treatment outcomes. Effective treatment of bladder cancer involves a multi-pronged approach, combining medical and surgical care, lifestyle adjustments, continuous support, as well as advanced treatments like immunotherapy, targeted therapy, participation in clinical trials, and consistent follow-up.

Healthcare

23 hours ago

Primary open-angle glaucoma cases to grow to 10 million by 2033